首页> 美国卫生研究院文献>Yonsei Medical Journal >Influence of Methylenetetrahydrofolate Reductase C677T Polymorphism on the Risk of Lung Cancer and the Clinical Response to Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer: An Updated Meta-Analysis

【2h】

Influence of Methylenetetrahydrofolate Reductase C677T Polymorphism on the Risk of Lung Cancer and the Clinical Response to Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer: An Updated Meta-Analysis

机译：亚甲基四氢叶酸还原酶C677T多态性对晚期非小细胞肺癌肺癌风险和对铂类化疗的临床反应的影响：最新荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

PurposeMethylenetetrahydrofolate reductase (MTHFR) has been implicated in lung cancer risk and response to platinum-based chemotherapy in advanced non-small cell lung cancer (NSCLC). However, the results are controversial. We performed meta-analysis to investigate the effect of MTHFR C677T polymorphism on lung cancer risk and response to platinum-based chemotherapy in advanced NSCLC.

机译：目的亚甲基四氢叶酸还原酶（MTHFR）与晚期非小细胞肺癌（NSCLC）的肺癌风险和对铂类化学疗法的反应有关。但是，结果是有争议的。我们进行了荟萃分析，以研究MTHFR C677T多态性对晚期NSCLC肺癌风险和对铂类化疗的反应的影响。

著录项

期刊名称 Yonsei Medical Journal
作者
Ning Zhu; Yi Gong; Jian He; Jingwen Xia; Xiaodong Chen;
展开▼
作者单位

展开▼
年(卷),期 2013(54),6
年度 2013
页码 1384–1393
总页数 10
原文格式 PDF
正文语种
中图分类基础医学;
关键词
MTHFR C677T polymorphism lung cancer platinum-based chemotherapy;

机译：MTHFR;C677T;多态性;肺癌;铂类化疗;

相似文献

外文文献
中文文献
专利

1. Influence of Methylenetetrahydrofolate Reductase C677T Polymorphism on the Risk of Lung Cancer and the Clinical Response to Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer: An Updated Meta-Analysis [J] . Zhu Ning, Gong Yi, He Jian, Yonsei Medical Journal . 2013,第6期

机译：亚甲基四氢叶酸还原酶C677T多态性对肺癌风险和晚期非小细胞肺癌对铂类化疗的临床反应的影响：最新荟萃分析
2. Heterozygote advantage of methylenetetrahydrofolate reductase polymorphisms on clinical outcomes in advanced non-small cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy. [J] . Xiaoying Li, Minhua Shao, Shiming Wang, Tumour biology : . 2014,第11期

机译：亚甲基四氢叶酸还原酶多态性的杂合子优势对接受铂类化学疗法治疗的晚期非小细胞肺癌（NSCLC）患者的临床结局具有优势。
3. Methylenetetrahydrofolate reductase C677T polymorphism predicts response and time to progression to gemcitabine-based chemotherapy for advanced non-small cell lung cancer in a Chinese Han population [J] . Wei Hong, Kai Wang, Yi-ping Zhang, Journal of Zhejiang University. Science, B . 2013,第3期

机译：甲基四乙烯酸还原酶C677T多态性预测中国汉族人群中晚期非小细胞肺癌的吉西他滨化疗进展的响应和时间
4. The clinical efficacy of transfusion of cytokine-induced killer cells combined with chemotherapy and XiaoJi decoction in patients with stage IIIB/IV non-small cell lung cancer [C] . Liuning Li, Jiaying Liu, Xiaoshu Chai, IEEE International Conference on Bioinformatics and Biomedicine . 2014

机译：细胞因子诱导的杀伤细胞输注结合化学疗法和消积汤治疗IIIB / IV期非小细胞肺癌的临床疗效
5. Symptoms Leading to Nutritional Risk in Advanced Non-Small Cell Lung Cancer Patients: The Importance of Nutritional Screening in the Advanced Lung Cancer Population [D] . Swinton, Nelda. 2009

机译：导致晚期非小细胞肺癌患者营养风险的症状：在晚期肺癌人群中进行营养筛查的重要性
6. Methylenetetrahydrofolate reductase C677T polymorphism predicts response and time to progression to gemcitabine-based chemotherapy for advanced non-small cell lung cancer in a Chinese Han population [O] . Wei Hong, Kai Wang, Yi-ping Zhang, 2013

机译：亚甲基四氢叶酸还原酶C677T多态性预测中国汉族人群晚期吉非他滨化疗对吉西他滨化疗的反应和进展时间
7. Influence of Methylenetetrahydrofolate Reductase C677T Polymorphism on the Risk of Lung Cancer and the Clinical Response to Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer: An Updated Meta-Analysis [O] . Ning Zhu, Yi Gong, Jian He, 2013

机译：甲基四氢盐还原酶C677T多态性对肺癌风险的影响及对铂基化疗的高小细胞肺癌的临床反应：更新的荟萃分析

Influence of Methylenetetrahydrofolate Reductase C677T Polymorphism on the Risk of Lung Cancer and the Clinical Response to Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer: An Updated Meta-Analysis

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅